INTERNATIONAL PATENT: IMPACT THERAPEUTICS (SHANGHAI),INC., IMPACT THERAPEUTICS, INC FILES APPLICATION FOR "HETEROARYL COMPOUNDS AS RNA HELICASE DHX9 INHIBITORS AND USE THEREOF"

GENEVA, Jan. 26 -- IMPACT THERAPEUTICS (SHANGHAI) , INC. (Room 603, No.3 Building, 111 Xiangke Road, China (Shanghai) Pilot Free Trade ZonePudong New Area, Shanghai 201210), IMPACT THERAPEUTICS, INC (No. 10 Xinghuo Road, Nanjing High-Tech Development ZoneNanjing, Jiangsu 210061) filed a patent application (PCT/CN2025/109117) for "HETEROARYL COMPOUNDS AS RNA HELICASE DHX9 INHIBITORS AND USE THEREOF" on Jul 17, 2025. With publication no. WO/2026/017124, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CAI, Sui Xiong (Room 01...